Tissue plasminogen activator in cardiac arrest with pulseless electrical activity

New England Journal of Medicine

Volumn 346, Issue 20, 2002, Pages 1522-1528

  Abu Laban, Riyad B ^a,d   Christenson, James M ^a,b,c   Innes, Grant D ^a,c   Van Beek, Catherina A ^a   Wanger, Karen P ^a,b   Douglas McKnight, R ^a   MacPhail, Iain A ^a,b   Puskaric, Joe ^b   Sadowski, Richard P ^b   Singer, Joel ^c   Schechter, Martin T ^c   Wood, Victor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Ambulance Service   (Canada)

^c Centre for Health Evaluation and Outcome Sciences   (Canada)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA DISSECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; ELECTRIC ACTIVITY; EXCITATION CONTRACTION COUPLING; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART ARREST; HEART MUSCLE POTENTIAL; HEART RUPTURE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; STATISTICAL ANALYSIS;

CARDIOPULMONARY RESUSCITATION; DOUBLE-BLIND METHOD; ELECTROPHYSIOLOGY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HEART ARREST; PULSE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE;

EID: 0037118292     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa012885     Document Type: Article

References (40)

1. Cardiac resuscitation
2. Importance of outside hospital mortality as a first acute ischemic heart event: The Quebec Cardiovascular Study
3. Electromechanical dissociation: Six years prehospital experience
4. Diagnostic accuracy of transesophageal echocardiography during cardiopulmonary resuscitation
5. Echocardiographic observations during in hospital cardiopulmonary resuscitation
6. Is there a pulse?
7. The management of electromechanical dissociation
8. Electromechanical dissociation: Pathological explanations in 50 patients
9. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest
10. Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator: Efficacy of dosing regimes
11. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension: Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics
12. Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022
13. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest
14. Cardiac arrest and the role of thrombolytic agents
15. Hochdosierte streptokinasetherapie bei fulminanter lungenarterienembolie
16. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator
17. Thrombolyse bei reanimierten patienten mit lungenembolie
18. Lysetherapie bie protraheirter kardiopulmonaler reanimation: Nutzen und komplikationen
19. High-dose bolus injection of urokinase: Use during cardiopulmonary resuscitation for massive pulmonary embolism
20. Survival from catastrophic intraoperative pulmonary embolism
21. Erfolgreiche reanimation nach bolusinjektion von gewebe-plasminogen aktivator in der notaufnahme
22. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: Outcome of a case series
23. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial
24. Out-of-hospital thrombolysis in cardiac arrest after unsuccessful resuscitation
25. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest
26. Guidelines for cardiopulmonary resuscitation and emergency cardiac care
27. The Utstein style for uniform reporting of data from out-of-hospital cardiac arrest
28. A comparison of low-molecularweight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
29. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial
30. Adding up the Glasgow Coma Score
31. A randomized clinical study of cardiopulmonary-cerebral resuscitation: Design, methods, and patient characteristics
32. Assessment of outcome after severe brain damage
33. The Modified Mini-Mental State (3MS) examination
34. The Functional Status Questionnaire: Reliability and validity when used in primary care
35. The problem of consent in emergency medicine research
36. Distinct criteria for termination of resuscitation in the out-of-hospital setting
37. Thrombolytic therapy during cardiopulmonary resuscitation
38. Single bolus administration of recombinant tissue plasminogen activator: Effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion
39. Bolus thrombolytic infusions during CPR
40. Pulmonary embolism as a cause of cardiac arrest: Presentation and outcome